(2-Methoxypyrimidin-5-yl)methanamine, 95.0%, 500mg

4-Hydroxypyridine-3-sulfonic Acid>98.0%(HPLC)(T)25g

rac-(3R,4S)-4-bromotetrahydro-3-thiopheneol 1,1-dioxide, 95.0%, 5g

BRETYLIUM TOSYLATE, 95%, 5g

Bis(4-(2,4,4-trimethylpentan-2-yl)phenyl)amine, 90.0%, 100g

Carbonate de potassium, min 98%, 25 kg, emballage plastique.

Plan PLPHi S40x/0.65 objectif corrigé à l'infini IOS à contraste de phase

TERT-BUTYL 3-CARBAMOYL-4-(1H-IMIDAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

DL-�-(3-Chlorophenyl)alaninol, 97.0%, 1g

SODIUM ACETATE-13C2, 95.0%, 1g

(R)-(+)-2-(Boc-Amino)-1,4-butanediol, 95.0%, 250mg

Hexanal 2,4-Dinitrophenylhydrazone>98.0%(HPLC)(T)1g

Methyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-naphthoate, 95.0%, 1g